Developing a new imaging technique for breast cancer diagnosis
A Computational Framework Enabling Virtual Imaging Trials of 3D Quantitative Optoacoustic Tomography Breast Imaging
This study is testing a new, safe imaging technique that uses light to create detailed pictures of breast tumors, helping doctors find and track breast cancer more accurately without using harmful radiation.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-11079601 on NIH RePORTER |
What this research studies
This research focuses on creating a non-invasive imaging method called optoacoustic tomography (OAT) to improve breast cancer diagnosis. By utilizing the natural optical properties of hemoglobin in tissues, this technique aims to provide detailed images of breast tumors without exposing patients to ionizing radiation. The study will address current limitations in imaging accuracy and resolution, ultimately enhancing the ability to detect and monitor breast cancer effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing evaluation for breast cancer or those with a high risk of developing the disease.
Not a fit: Patients who have already been diagnosed with advanced breast cancer and are not seeking imaging options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and safer breast cancer imaging techniques, improving early detection and treatment outcomes for patients.
How similar studies have performed: While optoacoustic tomography is a relatively novel approach, preliminary studies have shown promise in similar imaging techniques for other applications.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Anastasio, Mark a — University of Illinois at Urbana-Champaign
- Study coordinator: Anastasio, Mark a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.